A bill to suspend temporarily the duty on DCDNBTF Benzene, 2,4-dichloro-1,3-dinitro-5-(trifluoroethyl)-.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,048 other S bills in the 111th — cohort avg 29d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2012 · fourth_quarter · Tariff (miscellaneous tariff bills)
Issues related to Miscellaneous Tariff Bills S. 2661/H.R. 4915, including provisions related to Agelon 400 S. 2660/H.R. 4916, including provisions related to brine electrolizers S. 2663/H.R. 5455, including provisions related to pigment violet 23 S. 2662/H.R. 5457, including provisions related to titanium dioxide S. 2659/H.R. 5456, including provisions related to melanine resin H.R. 6727, the US Jobs Creation and Manufacturing Competitiveness Act, including provisions relating to tariff relief
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $50,000
Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), SENATE
2012 · fourth_quarter · Tariff (miscellaneous tariff bills)
Issues related to Miscellaneous Tariff Relief S. 3292, the Temporary Duty Suspension Process Act, including provisions realting to tariff relief process S. 2661/H.R. 4915, including provisions relating to Agelon 400 S. 2660/H.R. 4916, including provisions relating to brine electrolizers S. 2663/H.R. 5455, including provisions relating to pigment violet 23 S. 2662/H.R. 5457, including provisions relating to titanium dioxide S. 2659/H.R. 5456, including provisions relating to melanine resin H.R. 6727, the US Jobs Creation and Manufacturing Competitiveness Act, including provisions relating to tariff relief
Client expense: $201,094 · Firm income: Not reported
Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), Office of Management & Budget (OMB), SENATE, U.S. Information Agency (USIA), White House Office
2012 · third_quarter · Tariff (miscellaneous tariff bills)
Issues related to Miscellaneous Tariff Bills S. 2661/H.R. 4915, including provisions related to Agelon 400 S. 2660/H.R. 4916, including provisions related to brine electrolizers S. 2663/H.R. 5455, including provisions related to pigment violet 23 S. 2662/H.R. 5457, including provisions related to titanium dioxide S. 2659/H.R. 5456, including provisions related to melanine resin
Client expense: Not reported · Firm income: $60,000
Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), SENATE
2012 · third_quarter · Tariff (miscellaneous tariff bills)
Issues related to Miscellaneous Tariff Relief S. 3292, the Temporary Duty Suspension Process Act, including provisions realting to tariff relief process S. 2661/H.R. 4915, including provisions relating to Agelon 400 S. 2660/H.R. 4916, including provisions relating to brine electrolizers S. 2663/H.R. 5455, including provisions relating to pigment violet 23 S. 2662/H.R. 5457, including provisions relating to titanium dioxide S. 2659/H.R. 5456, including provisions relating to melanine resin
Client expense: $223,091 · Firm income: Not reported
Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), Office of Management & Budget (OMB), SENATE, U.S. Information Agency (USIA), White House Office
2012 · second_quarter · Tariff (miscellaneous tariff bills)
Issues related to Miscellaneous Tariff Relief H.R. 2072, the Securing American Jobs Through Exports Act, including provisions relating to the Export-Import bank S. 3292, the Temporary Duty Suspension Process Act, including provisions realting to tariff relief process S. 2661/H.R. 4915, including provisions relating to Agelon 400 S. 2660/H.R. 4916, including provisions relating to brine electrolizers S. 2663/H.R. 5455, including provisions relating to pigment violet 23 S. 2662/H.R. 5457, including provisions relating to titanium dioxide S. 2659/H.R. 5456, including provisions relating to melanine resin
Client expense: $229,865 · Firm income: Not reported
Government targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), U.S. Information Agency (USIA), White House Office
2012 · second_quarter · Tariff (miscellaneous tariff bills)
Issues related to Miscellaneous Tariff Bills S. 2661/H.R. 4915, including provisions related to Agelon 400 S. 2660/H.R. 4916, including provisions related to brine electrolizers S. 2663/H.R. 5455, including provisions related to pigment violet 23 S. 2662/H.R. 5457, including provisions related to titanium dioxide S. 2659/H.R. 5456, including provisions related to melanine resin
Client expense: Not reported · Firm income: $60,000
Government targets: Army, Dept of (Other), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Consumer Issues/Safety/Products
S.2663 The Consumer Safety Commission Reform Act - H.R. 4040 The Consumer Product Safety Commission Reform Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · second_quarter · Consumer Issues/Safety/Products
S.2663 The Consumer Safety Commission Reform Act - H.R. 4040 The Consumer Product Safety Commission Reform Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Consumer Issues/Safety/Products
S.2663 The Consumer Safety Commission Reform Act - H.R. 4040 The Consumer Product Safety Commission Reform Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Consumer Issues/Safety/Products
S.2663 The Consumer Safety Commission Reform Act - H.R. 4040 The Consumer Product Safety Commission Reform Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Consumer Issues/Safety/Products
S.2663 The Consumer Safety Commission Reform Act - H.R. 4040 The Consumer Product Safety Commission Reform Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · second_quarter · Consumer Issues/Safety/Products
S.2663 The Consumer Safety Commission Reform Act - H.R. 4040 The Consumer Product Safety Commission Reform Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · first_quarter · Consumer Issues/Safety/Products
S.2663 The Consumer Safety Commission Reform Act - H.R. 4040 The Consumer Product Safety Commission Reform Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Consumer Issues/Safety/Products
S.2663 The Consumer Safety Commission Reform Act - H.R. 4040 The Consumer Product Safety Commission Reform Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Consumer Issues/Safety/Products
S.2663 The Consumer Safety Commission Reform Act - H.R. 4040 The Consumer Product Safety Commission Reform Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Consumer Issues/Safety/Products
S. 2663 The Consumer Safety Commission Reform Act - H.R. 4040 The Consumer Product Safety Commission Reform Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Consumer Issues/Safety/Products
S.2663 The Consumer Safety Commission Reform Act - H.R. 4040 The Consumer Product Safety Commission Reform Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Consumer Issues/Safety/Products
S.2663 The Consumer Safety Commission Reform Act - H.R. 4040 The Consumer Product Safety Commission Reform Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Consumer Issues/Safety/Products
S.2663 The Consumer Product Safety Commission Reform Act - H.R. 4040 The Consumer Product Safety Commission Reform Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Health Issues
Affordable Health Choice Act. S301 Physician Payments Sunshine Act 2009. HR380, S623, Access to Life-Saving Medicine Act; Follow-on biologics, importation, HR3610 Food and Drug Safety Act of 2007: Import safety; HR5839, Safeguard Americans Pharmaceuticals Act; S2029, Physician's Payment Sunshine Act; Reporting periodicity, pre-emption. HR1427 and HR1038, Access to Life-Saving Medicine Act; follow-on biologics; HR1956, Patient Protection and Innovative Biologic Medicines Act of 2007; follow-on biologics; HR3610, Food and Drug Import Safety Act of 2007; Import safety HR 6151, Responsibilty in Drug and Device Advertising Act of 2008: Direct-to-consumer advertising; S 242, Pharmaceutical Market Acess and Drug Safety Act of 2007: importation; S 334, Healthy Americans Act: non-interference; S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs; S 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics; S 2663, CPSC Reform Act: importation; S 3398, Medical Device Safety Act of 2008: preemption issues; S 3409, Drug and Device Accountability Act of 2008: import safety
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Consumer Issues/Safety/Products
S.2663 The Consumer Product Safety Commission Reform Act - H.R. 4040 The Consumer Product Safety Commission Reform Act
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Health Issues
HR 2 Children's Health Insurance Program Reauthorization Act 2009. S301 Physician Payments Sunshine Act 2009. HR380, S623, Access to Life-Saving Medicine Act; Follow-on biologics, importation, HR3610 Food and Drug Safety Act of 2007: Import safety; HR5839, Safeguard Americans Pharmaceuticals Act; S2029, Physician's Payment Sunshine Act; Reporting periodicity, pre-emption. HR1427 and HR1038, Access to Life-Saving Medicine Act; follow-on biologics; HR1956, Patient Protection and Innovative Biologic Medicines Act of 2007; follow-on biologics; HR3610, Food and Drug Import Safety Act of 2007; Import safety HR 6151, Responsibilty in Drug and Device Advertising Act of 2008: Direct-to-consumer advertising; S 242, Pharmaceutical Market Acess and Drug Safety Act of 2007: importation; S 334, Healthy Americans Act: non-interference; S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs; S 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics; S 2663, CPSC Reform Act: importation; S 3398, Medical Device Safety Act of 2008: preemption issues; S 3409, Drug and Device Accountability Act of 2008: import safety
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Consumer Issues/Safety/Products
S. 2663 The Consumer Product Safety Commission Reform Act - H.R. 4040 The Consumer Product Safety Commission Reform Act.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE